IL139166A0 - Anti- viral compounds - Google Patents
Anti- viral compoundsInfo
- Publication number
- IL139166A0 IL139166A0 IL13916698A IL13916698A IL139166A0 IL 139166 A0 IL139166 A0 IL 139166A0 IL 13916698 A IL13916698 A IL 13916698A IL 13916698 A IL13916698 A IL 13916698A IL 139166 A0 IL139166 A0 IL 139166A0
- Authority
- IL
- Israel
- Prior art keywords
- viral compounds
- viral
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/010299 WO1999059587A1 (en) | 1998-05-20 | 1998-05-20 | Anti-viral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL139166A0 true IL139166A0 (en) | 2001-11-25 |
Family
ID=22267098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13916698A IL139166A0 (en) | 1998-05-20 | 1998-05-20 | Anti- viral compounds |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1077701A4 (en) |
| JP (1) | JP2002515433A (en) |
| KR (1) | KR20010025055A (en) |
| CN (1) | CN1292697A (en) |
| AU (1) | AU7583098A (en) |
| BR (1) | BR9815899A (en) |
| CA (1) | CA2332403A1 (en) |
| CZ (1) | CZ289425B6 (en) |
| EA (1) | EA200001208A1 (en) |
| HU (1) | HUP0102117A2 (en) |
| IL (1) | IL139166A0 (en) |
| NO (1) | NO20005795L (en) |
| SK (1) | SK17482000A3 (en) |
| TR (1) | TR200003414T2 (en) |
| WO (1) | WO1999059587A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR213700A0 (en) | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
| AR048650A1 (en) * | 2004-05-04 | 2006-05-10 | Tibotec Pharm Ltd | DERIVATIVES OF (1,10B-DIHIDRO-2- (AMINOCARBONIL-PHENYL) -5H-PIRAZOLO [1,5 C] [1,3] BENZOXAZIN-5-IL) METHANONE PHENYL AS INHIBITORS OF HIV VIRAL REPLICATION |
| ATE462697T1 (en) | 2004-08-12 | 2010-04-15 | Amgen Inc | BISARYL SULFONAMIDES |
| US7666880B2 (en) | 2005-03-21 | 2010-02-23 | S*Bio Pte Ltd. | Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications |
| WO2006101455A1 (en) * | 2005-03-21 | 2006-09-28 | S*Bio Pte Ltd | Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| ES2395386T3 (en) | 2005-12-21 | 2013-02-12 | Abbott Laboratories | Antiviral compounds |
| AU2006330924B2 (en) | 2005-12-21 | 2012-03-15 | Abbvie Inc. | Anti-viral compounds |
| DE602006015861D1 (en) | 2005-12-21 | 2010-09-09 | Abbott Lab | ANTIVIRAL CONNECTIONS |
| TWI399380B (en) | 2006-12-20 | 2013-06-21 | Abbott Lab | Anti-viral compounds |
| CN102046621B (en) * | 2008-05-27 | 2014-11-12 | 生物区科学管理控股有限公司 | Antiviral salts |
| JP2012513409A (en) | 2008-12-23 | 2012-06-14 | アボット・ラボラトリーズ | Antiviral compounds |
| CN102245604A (en) | 2008-12-23 | 2011-11-16 | 雅培制药有限公司 | Anti-viral compounds |
| RU2541571C2 (en) * | 2009-04-15 | 2015-02-20 | Эббви Инк. | Antiviral compounds |
| WO2014060381A1 (en) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclic compounds as pesticides |
| EP2914587A1 (en) | 2012-10-31 | 2015-09-09 | Bayer CropScience AG | Novel heterocyclic compounds as pest control agents |
| CN104370732B (en) * | 2014-01-26 | 2015-08-19 | 山东信立泰药业有限公司 | The preparation method of a kind of clopidogrel and intermediate thereof |
| CN109535405B (en) * | 2017-09-21 | 2021-07-30 | 宁波聚嘉新材料科技有限公司 | Preparation method of polyarylate based on 2- (4-carboxyphenyl) -5-hydroxypyridoimidazole |
| CN109810085B (en) * | 2019-04-19 | 2019-07-19 | 上海皓元生物医药科技有限公司 | The preparation method of ACC inhibitor and its intermediate |
| CN110746450A (en) * | 2019-09-17 | 2020-02-04 | 济南康和医药科技有限公司 | Synthetic method of beraprost sodium key intermediate |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4096264A (en) * | 1975-12-09 | 1978-06-20 | Merck & Co., Inc. | Certain substituted imidazo [1,2-a] pyridines |
| US4250174A (en) * | 1979-05-02 | 1981-02-10 | Merck & Co., Inc. | 3-Substituted imidazo [1,2-A] pyridines |
| US5693661A (en) * | 1995-06-07 | 1997-12-02 | Eli Lilly And Company | Anti-viral compounds |
| US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
| BR9709528A (en) * | 1996-06-05 | 1999-08-10 | Lilly Co Eli | Antiviral compounds |
| US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
-
1998
- 1998-05-20 CZ CZ20004278A patent/CZ289425B6/en unknown
- 1998-05-20 AU AU75830/98A patent/AU7583098A/en not_active Abandoned
- 1998-05-20 SK SK1748-2000A patent/SK17482000A3/en unknown
- 1998-05-20 EP EP98923565A patent/EP1077701A4/en not_active Withdrawn
- 1998-05-20 HU HU0102117A patent/HUP0102117A2/en unknown
- 1998-05-20 KR KR1020007012999A patent/KR20010025055A/en not_active Application Discontinuation
- 1998-05-20 CA CA002332403A patent/CA2332403A1/en not_active Abandoned
- 1998-05-20 WO PCT/US1998/010299 patent/WO1999059587A1/en not_active Application Discontinuation
- 1998-05-20 EA EA200001208A patent/EA200001208A1/en unknown
- 1998-05-20 TR TR2000/03414T patent/TR200003414T2/en unknown
- 1998-05-20 IL IL13916698A patent/IL139166A0/en unknown
- 1998-05-20 CN CN988140519A patent/CN1292697A/en active Pending
- 1998-05-20 BR BR9815899-6A patent/BR9815899A/en not_active IP Right Cessation
- 1998-05-20 JP JP2000549252A patent/JP2002515433A/en not_active Withdrawn
-
2000
- 2000-11-16 NO NO20005795A patent/NO20005795L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9815899A (en) | 2001-02-20 |
| JP2002515433A (en) | 2002-05-28 |
| CA2332403A1 (en) | 1999-11-25 |
| NO20005795D0 (en) | 2000-11-16 |
| EP1077701A4 (en) | 2002-03-20 |
| SK17482000A3 (en) | 2005-03-04 |
| TR200003414T2 (en) | 2001-03-21 |
| EA200001208A1 (en) | 2001-06-25 |
| CZ20004278A3 (en) | 2001-05-16 |
| HUP0102117A2 (en) | 2001-12-28 |
| AU7583098A (en) | 1999-12-06 |
| CN1292697A (en) | 2001-04-25 |
| EP1077701A1 (en) | 2001-02-28 |
| WO1999059587A1 (en) | 1999-11-25 |
| NO20005795L (en) | 2001-01-18 |
| CZ289425B6 (en) | 2002-01-16 |
| KR20010025055A (en) | 2001-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9804734D0 (en) | Compounds | |
| GB9804175D0 (en) | Compounds | |
| IL139166A0 (en) | Anti- viral compounds | |
| GB9818689D0 (en) | Compounds | |
| GB9818881D0 (en) | Compounds | |
| EP1001767A4 (en) | Anti-viral compounds | |
| GB9809823D0 (en) | Compounds | |
| GB9810876D0 (en) | Compounds | |
| GB9812522D0 (en) | Compounds | |
| GB9801712D0 (en) | Compounds | |
| GB9809217D0 (en) | Compounds | |
| GB9804337D0 (en) | Anti-viral compounds | |
| PL344262A1 (en) | Anti-viral compounds | |
| GB9906211D0 (en) | Anti-viral compounds | |
| GB9809609D0 (en) | Anti-viral compounds | |
| GB9720837D0 (en) | Anti-viral compounds | |
| GB9623132D0 (en) | Anti-viral guanidino-substituted compounds | |
| GB9609306D0 (en) | Anti-viral compounds | |
| GB9806699D0 (en) | Compounds | |
| GB9801100D0 (en) | Compounds | |
| GB9805447D0 (en) | Compounds | |
| GB9806379D0 (en) | Compounds | |
| GB9806690D0 (en) | Compounds | |
| GB9805133D0 (en) | Compounds | |
| GB9806701D0 (en) | Compounds |